PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer.
Saved in:
| Title: | PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer. |
|---|---|
| Authors: | Parejo-Alonso B; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Barneda D; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Trabulo SMD; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Courtois S; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Compte-Sancerni S; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Zurkovic J; LIMES Life and Medical Sciences Institute, University of Bonn, Bonn, Germany., Ruiz-Cañas L; Department of Biochemistry, Autónoma University of Madrid (UAM), School of Medicine, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Zheng Q; Center for Single-Cell Omics and State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Tang J; Center for Single-Cell Omics and State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Gaida MM; Institute of Pathology, University Medical Center Mainz, JGU-Mainz, Mainz, Germany.; TRON Translational Oncology at the University Medical Center, JGU-Mainz, Mainz, Germany.; Research Center for Immunotherapy, University Medical Center Mainz, JGU-Mainz, Mainz, Germany., Schmitz U; Computational Biomedicine Lab, College of Science and Engineering, James Cook University, Townsville, Australia., Irun P; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain.; Liver and Digestive Diseases Networking Biomedical Research Centre (CIBEREHD), Carlos III Health Institute (ISCIII), Zaragoza, Spain., Penin-Peyta L; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Crusz SM; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Jagušt P; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Espiau-Romera P; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Royo-García A; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Gordo-Ortiz A; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Yuneva M; Oncogenes and Tumour Metabolism Laboratory, Francis Crick Institute, London, United Kingdom., Lin ML; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Huang S; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Pancreatic Cancer Heterogeneity, Candiolo Cancer Institute - FPO - IRCCS, Torino, Italy., Yang MH; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan., Lanas A; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain.; Liver and Digestive Diseases Networking Biomedical Research Centre (CIBEREHD), Carlos III Health Institute (ISCIII), Zaragoza, Spain.; Department of Gastroenterology, Hospital Universitario Lozano Blesa, Universidad de Zaragoza, Zaragoza, Spain., Sainz B Jr; Department of Biochemistry, Autónoma University of Madrid (UAM), School of Medicine, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Thiele C; LIMES Life and Medical Sciences Institute, University of Bonn, Bonn, Germany., Heeschen C; Pancreatic Cancer Heterogeneity, Candiolo Cancer Institute - FPO - IRCCS, Torino, Italy., Sancho P; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain.; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom. |
| Source: | Cancer research [Cancer Res] 2025 Sep 02; Vol. 85 (17), pp. 3275-3291. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
